Seeking Alpha
23 Sept 2026, 19:54 UTC · 54m ago
Verdict
Source says Buy. We score MDT +0.80 across four claims.
Score confirms the headline.
Buy
Rating stated in the headline
+0.80strongly bullish
What the story claims
4 claims · scored −1 bearish … +1 bullish · 0 new · 4 priced in
Medtronic raised its revenue and EPS guidance following Q1 FY27 results.
Priced inanalysis of Q1 FY27 results
So whatThe guidance hike likely shifts the FY2027 EPS baseline upward for the next print.
More positive than 92% of claims this week
Normalized revenue growth reached 7% in Q1 FY27, led by Cardiovascular and Neuroscience.
Continue reading
5 related stories
More positive than 86% of ticker scores this week
Scored by the NIS engine · methodology.
Priced inanalysis of Q1 FY27 results
So whatGrowth acceleration in these segments provides the foundation for the 17% target upside.
More positive than 77% of claims this week
Margin expansion is expected to materialize gradually as product mix shifts toward recurring revenues.
Priced inanalysis of Q1 FY27 results
So whatGradual realization implies that significant margin beats are unlikely before H2 FY2027.
More positive than 51% of claims this week
Medtronic currently offers a 3% dividend yield.
Priced inanalysis of Q1 FY27 results
So whatThis yield provides a valuation floor that limits downside risk relative to the $106.33 target.
More positive than 42% of claims this week
Which stocks this story touches
More positive than 86% of ticker scores this week
Initiated with a buy rating, exceeded Q1 expectations, and raised guidance for revenue and EPS.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
2h ago
−1.6%
Price is moving against the score
$89.31 vs $90.77 close before publication (Sep 22) · not market-adjusted
MDT chart →
